The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biosimilar Testing and Development Services-Global Market Insights and Sales Trends 2024
Synopsis
The global Biosimilar Testing and Development Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biosimilar Testing and Development Services in various end use industries. The expanding demands from the PK assay, Tiered Immunogenicity testing and NAb assays,, are propelling Biosimilar Testing and Development Services market. Effector Binding, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA segment is estimated at % CAGR for the next seven-year period.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimilar Testing and Development Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimilar Testing and Development Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimilar Testing and Development Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimilar Testing and Development Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimilar Testing and Development Services covered in this report include Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri and Pace Analytical Services, etc.
The global Biosimilar Testing and Development Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Global Biosimilar Testing and Development Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimilar Testing and Development Services market, Segment by Type:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Global Biosimilar Testing and Development Services market, by Application
PK assay
Tiered Immunogenicity testing
NAb assays
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimilar Testing and Development Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biosimilar Testing and Development Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biosimilar Testing and Development Services in various end use industries. The expanding demands from the PK assay, Tiered Immunogenicity testing and NAb assays,, are propelling Biosimilar Testing and Development Services market. Effector Binding, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA segment is estimated at % CAGR for the next seven-year period.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimilar Testing and Development Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimilar Testing and Development Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimilar Testing and Development Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimilar Testing and Development Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimilar Testing and Development Services covered in this report include Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri and Pace Analytical Services, etc.
The global Biosimilar Testing and Development Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Global Biosimilar Testing and Development Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimilar Testing and Development Services market, Segment by Type:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Global Biosimilar Testing and Development Services market, by Application
PK assay
Tiered Immunogenicity testing
NAb assays
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimilar Testing and Development Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biosimilar Testing and Development Services
1.1 Biosimilar Testing and Development Services Market Overview
1.1.1 Biosimilar Testing and Development Services Product Scope
1.1.2 Biosimilar Testing and Development Services Market Status and Outlook
1.2 Global Biosimilar Testing and Development Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biosimilar Testing and Development Services Market Size by Region (2018-2029)
1.4 Global Biosimilar Testing and Development Services Historic Market Size by Region (2018-2023)
1.5 Global Biosimilar Testing and Development Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biosimilar Testing and Development Services Market Size (2018-2029)
1.6.1 North America Biosimilar Testing and Development Services Market Size (2018-2029)
1.6.2 Europe Biosimilar Testing and Development Services Market Size (2018-2029)
1.6.3 Asia-Pacific Biosimilar Testing and Development Services Market Size (2018-2029)
1.6.4 Latin America Biosimilar Testing and Development Services Market Size (2018-2029)
1.6.5 Middle East & Africa Biosimilar Testing and Development Services Market Size (2018-2029)
2 Biosimilar Testing and Development Services Market by Type
2.1 Introduction
2.1.1 Effector Binding
2.1.2 ELISA
2.1.3 Kinetic Binding Assays
2.1.4 ADCC & CDC Cell-Based Assays
2.2 Global Biosimilar Testing and Development Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2018-2023)
2.2.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biosimilar Testing and Development Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biosimilar Testing and Development Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biosimilar Testing and Development Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biosimilar Testing and Development Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biosimilar Testing and Development Services Revenue Breakdown by Type (2018-2029)
3 Biosimilar Testing and Development Services Market Overview by Application
3.1 Introduction
3.1.1 PK assay
3.1.2 Tiered Immunogenicity testing
3.1.3 NAb assays
3.2 Global Biosimilar Testing and Development Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2018-2023)
3.2.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biosimilar Testing and Development Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biosimilar Testing and Development Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biosimilar Testing and Development Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biosimilar Testing and Development Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biosimilar Testing and Development Services Revenue Breakdown by Application (2018-2029)
4 Biosimilar Testing and Development Services Competition Analysis by Players
4.1 Global Biosimilar Testing and Development Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2022)
4.3 Date of Key Players Enter into Biosimilar Testing and Development Services Market
4.4 Global Top Players Biosimilar Testing and Development Services Headquarters and Area Served
4.5 Key Players Biosimilar Testing and Development Services Product Solution and Service
4.6 Competitive Status
4.6.1 Biosimilar Testing and Development Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eurofins Scientific
5.1.1 Eurofins Scientific Profile
5.1.2 Eurofins Scientific Main Business
5.1.3 Eurofins Scientific Biosimilar Testing and Development Services Products, Services and Solutions
5.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.1.5 Eurofins Scientific Recent Developments
5.2 SGS
5.2.1 SGS Profile
5.2.2 SGS Main Business
5.2.3 SGS Biosimilar Testing and Development Services Products, Services and Solutions
5.2.4 SGS Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.2.5 SGS Recent Developments
5.3 Charles River Laboratories
5.3.1 Charles River Laboratories Profile
5.3.2 Charles River Laboratories Main Business
5.3.3 Charles River Laboratories Biosimilar Testing and Development Services Products, Services and Solutions
5.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.3.5 Pharmaceutical Product Development Recent Developments
5.4 Pharmaceutical Product Development
5.4.1 Pharmaceutical Product Development Profile
5.4.2 Pharmaceutical Product Development Main Business
5.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Products, Services and Solutions
5.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.4.5 Pharmaceutical Product Development Recent Developments
5.5 Exova
5.5.1 Exova Profile
5.5.2 Exova Main Business
5.5.3 Exova Biosimilar Testing and Development Services Products, Services and Solutions
5.5.4 Exova Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.5.5 Exova Recent Developments
5.6 Source BioScience
5.6.1 Source BioScience Profile
5.6.2 Source BioScience Main Business
5.6.3 Source BioScience Biosimilar Testing and Development Services Products, Services and Solutions
5.6.4 Source BioScience Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.6.5 Source BioScience Recent Developments
5.7 Intertek Group
5.7.1 Intertek Group Profile
5.7.2 Intertek Group Main Business
5.7.3 Intertek Group Biosimilar Testing and Development Services Products, Services and Solutions
5.7.4 Intertek Group Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.7.5 Intertek Group Recent Developments
5.8 Medistri
5.8.1 Medistri Profile
5.8.2 Medistri Main Business
5.8.3 Medistri Biosimilar Testing and Development Services Products, Services and Solutions
5.8.4 Medistri Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.8.5 Medistri Recent Developments
5.9 Pace Analytical Services
5.9.1 Pace Analytical Services Profile
5.9.2 Pace Analytical Services Main Business
5.9.3 Pace Analytical Services Biosimilar Testing and Development Services Products, Services and Solutions
5.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.9.5 Pace Analytical Services Recent Developments
5.10 Sigma-Aldrich
5.10.1 Sigma-Aldrich Profile
5.10.2 Sigma-Aldrich Main Business
5.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Products, Services and Solutions
5.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue (US$ Million) & (2018-2023)
5.10.5 Sigma-Aldrich Recent Developments
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biosimilar Testing and Development Services Market Dynamics
11.1 Biosimilar Testing and Development Services Industry Trends
11.2 Biosimilar Testing and Development Services Market Drivers
11.3 Biosimilar Testing and Development Services Market Challenges
11.4 Biosimilar Testing and Development Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
